Medical Oncology Hematology Associates

Newark, New Jersey 19713

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, HER2-positive Breast Cancer

Studies at this site

• A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer — Recruiting now